Search

Your search keyword '"Willerslev-Olsen, Andreas"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Willerslev-Olsen, Andreas" Remove constraint Author: "Willerslev-Olsen, Andreas" Database Unpaywall Remove constraint Database: Unpaywall
35 results on '"Willerslev-Olsen, Andreas"'

Search Results

1. Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome

2. Endolysin Inhibits Skin Colonization by Patient-Derived Staphylococcus Aureus and Malignant T-Cell Activation in Cutaneous T-Cell Lymphoma

3. Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma

4. miRNA Signature in Early-stage Mycosis Fungoides

5. miRNA signature in early-stage mycosis fungoides

6. Staphylococcus aureus Induces Signal Transducer and Activator of Transcription 5‒Dependent miR-155 Expression in Cutaneous T-Cell Lymphoma

7. JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL)

9. The Thioredoxin-Interacting Protein TXNIP Is a Putative Tumour Suppressor in Cutaneous T-Cell Lymphoma

10. Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome

11. MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas

12. MicroRNA-93 Targets p21 and Promotes Proliferation in Mycosis Fungoides T Cells

13. Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma

14. Skin Associated Staphylococcus Aureus Contributes to Disease Progression in CTCL

15. Expression of the Voltage-Gated Potassium Channel Kv1.3 in Lesional Skin from Patients with Cutaneous T-Cell Lymphoma and Benign Dermatitis

16. Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome

17. Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma

18. Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4+ T cells in cutaneous T-cell lymphoma

19. Antibiotics inhibit tumor and disease activity in cutaneous T cell lymphoma

20. Prognostic miRNA classifier in early-stage mycosis fungoides: Development and validation in a Danish nationwide study

21. Single-cell heterogeneity in Sézary syndrome

22. SATB1 in Malignant T Cells

23. Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study

25. A novel BLK-induced tumor model

26. STAT5 induces miR-21 expression in cutaneous T cell lymphoma

27. The Expression of IL-21 Is Promoted by MEKK4 in Malignant T Cells and Associated with Increased Progression Risk in Cutaneous T-Cell Lymphoma

28. Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma

29. Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma

30. Epigenetic Silencing of Mir-203 Contributes to IL2Rb Overexpression and Malignant Transformation in Cutaneous T-Cell Lymphoma

31. Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation

32. IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF)

33. Bacterial Toxins Fuel Disease Progression in Cutaneous T-Cell Lymphoma

34. Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma

35. Vascular endothelial growth factor receptor-3 expression in mycosis fungoides

Catalog

Books, media, physical & digital resources